Recall of Vistide® deliveries causes no supply issues

The European Medicines Agency (EMA) has found that quality issues may have arisen in the production of the medicine Vistide® from the US company Ben Venue.

EMA has therefore recommended that the company recall all affected deliveries (batches) of Vistide® until the quality can be assured.

EMA considers the risk that the product does not meet the quality requirements to be small, but nevertheless recommends a precautionary recall of the product.

No affected batches of this medicine have been sold on the Danish market.

The EMA press release